Actavis, Inc. News Headlines

ACT 
$226.98
*  
0.39
0.17%
Get ACT Alerts
*Delayed - data as of Aug. 29, 2014  -  Find a broker to begin trading ACT now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Commit To Purchase Actavis At $155, Earn 6.8% Using Options
6/2/2014 11:39:57 AM - BNK Invest

Third Point Partners sells its position in Abbott Laboratories
5/26/2014 5:00:00 PM - Market Realist

Breakout Or Another Bluff? Bulls Seeking Confirmation This Week
5/26/2014 2:16:00 PM - Seeking Alpha

Dan Loeb’s Third Point Partners sells its shares in Yahoo
5/26/2014 1:00:00 PM - Market Realist

Dan Loeb and Third Point buy a 1Q14 position in Citrix Systems
5/26/2014 9:00:00 AM - Market Realist

Dan Loeb’s Third Point buys a new position in Roper Industries
5/23/2014 5:00:00 PM - Market Realist

Why I Don’t Follow the Dow
5/23/2014 2:48:00 PM - Cabot Heritage Corporation

Why Verizon Communications attracted Third Point’s interest
5/23/2014 1:00:00 PM - Market Realist

Dan Loeb’s Third Point Partners buys a position in CF Industries
5/23/2014 9:00:00 AM - Market Realist

Dan Loeb’s Third Point Partners buys a large stake in Actavis
5/22/2014 4:20:00 PM - Market Realist

Dan Loeb’s Third Point Partners: Key positions in 1Q 2014
5/22/2014 12:19:00 PM - Market Realist

Valeant: Poor Earnings Quality Masked By Acquisition Related Pro-Forma Reporting
5/21/2014 6:08:00 PM - Seeking Alpha

Celgene Asserts More Revlimid Patents, Seeks New Ones To 2031
5/20/2014 6:07:00 PM - Seeking Alpha

Tracking Carl Icahn's Portfolio - Q1 2014 Update
5/20/2014 1:46:00 AM - Seeking Alpha

Legal Setback for Eli Lilly in the UK - Analyst Blog
5/16/2014 4:10:00 PM - Zacks.com

J.P.Morgan's Geoff Meacham Plucks Biotechs With Upside From A Down Market
5/16/2014 9:17:00 AM - Seeking Alpha

Thoughts On The Celgene Revlimid Markman Hearing
5/16/2014 9:15:00 AM - Seeking Alpha

Why Pfizer’s proposed AstraZeneca takeover is tax-driven
5/14/2014 9:00:00 AM - Market Realist

The case for Pfizer’s proposed takeover of AstraZeneca
5/13/2014 1:06:00 PM - Market Realist

SSO, ACE, ACT, ADBE: Large Outflows Detected at ETF
5/13/2014 11:00:07 AM - BNK Invest

Vivus Discloses Competitive Threat
5/10/2014 10:51:00 AM - Seeking Alpha

Acorda Misses on Earnings, Beats Revs - Analyst Blog
5/7/2014 1:43:01 PM - Zacks.com

Earnings Beat at Endo, Shares Up on Improved Outlook - Analyst Blog
5/2/2014 12:10:01 PM - Zacks.com

Avanir Wins Lawsuit, Shares Up - Analyst Blog
5/1/2014 4:39:01 PM - Zacks.com

Mylan Beats on Earnings, Misses on Sales - Analyst Blog
5/1/2014 1:17:01 PM - Zacks.com